BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28656201)

  • 1. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.
    Ren CX; Leng RX; Fan YG; Pan HF; Li BZ; Wu CH; Wu Q; Wang NN; Xiong QR; Geng XP; Ye DQ
    Oncol Rep; 2017 Aug; 38(2):886-898. PubMed ID: 28656201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
    Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
    Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection.
    Shu QH; Ge YS; Ma HX; Gao XQ; Pan JJ; Liu D; Xu GL; Ma JL; Jia WD
    J Cell Mol Med; 2016 Jun; 20(6):1024-35. PubMed ID: 26843477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.
    Peng SL; Yao DB; Zhao Y; Xu F; Jia CJ; Xu YQ; Dai CL
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):38-44. PubMed ID: 25635973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma.
    Liu CQ; Xu J; Zhou ZG; Jin LL; Yu XJ; Xiao G; Lin J; Zhuang SM; Zhang YJ; Zheng L
    Br J Cancer; 2018 Jul; 119(1):80-88. PubMed ID: 29921949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma.
    Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X
    Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
    Wang YY; Qi LN; Zhong JH; Qin HG; Ye JZ; Lu SD; Ma L; Xiang BD; Li LQ; You XM
    Sci Rep; 2017 Feb; 7():42199. PubMed ID: 28181486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.
    Jing YY; Liu WT; Guo SW; Ye F; Fan QM; Yu GF; Yu DD; Gao L; Sun K; Han ZP; Li R; Yang Y; Zhao QD; Wu MC; Wang HY; Wei LX
    Oncotarget; 2015 Dec; 6(40):42952-62. PubMed ID: 26515593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage profile in primary versus secondary liver tumors.
    Avădănei ER; Wierzbicki PM; Giuşcă SE; Grigoraş A; Amălinei C; Căruntu ID
    Folia Histochem Cytobiol; 2014; 52(2):112-23. PubMed ID: 25007179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients.
    Wang MD; Xiang H; Hong TY; Mierxiati A; Yan FH; Zhang L; Wang C
    BMC Cancer; 2023 Jun; 23(1):593. PubMed ID: 37370037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
    Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection.
    Liu H; Liu W; Liu Z; Liu Y; Zhang W; Xu L; Xu J
    Tumour Biol; 2015 Jul; 36(7):5039-49. PubMed ID: 25722111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.
    Ding T; Xu J; Wang F; Shi M; Zhang Y; Li SP; Zheng L
    Hum Pathol; 2009 Mar; 40(3):381-9. PubMed ID: 18992916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
    Kong LQ; Zhu XD; Xu HX; Zhang JB; Lu L; Wang WQ; Zhang QB; Wu WZ; Wang L; Fan J; Tang ZY; Sun HC
    PLoS One; 2013; 8(3):e59771. PubMed ID: 23555776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.